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Introduction: 
Objectives: 
Fat mass development and alterations in adipocyte metabolism contribute to the progression of insulin resistance (IR) and Metabolic 
Syndrome (MetS). IR is a key element in MetS and results from ectopic fat depots in the liver and skeletal muscle when adipose tissue 
storage capacity is exceeded. Epidemiological and interventional studies show that n-3 PUFA protect against risk factor for 
cardiovascular diseases. Nutritional strategies using n-3 PUFA were also proposed to limit adipocyte expansion and metabolic 
alterations in other tissues which are associated to MetS. 
The aim of the present work was to compare the effect of ALA, EPA and DHA on the development of adipose tissue and its metabolism 
during a high fat-high sucrose (HFHS) challenge.  
C57BL6 and Ob/Ob mice were fed a HF (45% energy)-HS (17% energy) diet without or with 1% energy replaced by ALA, EPA or DHA 
for 16 and 6 weeks respectively. Body composition was evaluated using EchoMRI. Indirect gas calorimetry was performed with the TSE  
metabolic platform. mRNA and total DNA was isolated using Trizol Reagent from adipose tissue for gene expression (real time qPCR) 
and cellularity assessment. Leptin and adiponectin plasma levels were determined using A multiplex (BioRad) and ELISA (Marq) assay 
respectively. The Impact of each n-3 PUFA on the differentiation process of 3T3-L1 adipocytes was also evaluated in vitro.  Statistical 
Analyses were performed using an ANOVA and a Fisher Post-Hoc test. (See also the poster from Pinel et al. with other details) 
Long chain omega 3 fatty acids have distinct 
effects on adipose tissue cellularity and 
adipokine expression. Surprisingly, DHA 
increased leptin and reduced adiponectin 
expression. By contrast with ALA and DHA, 
EPA decreased adipose tissue PPARg mRNA 
level and prevent the increase in plasma 
leptin. Reduced adipocyte size could explain 
these preventive effects. 
Table 1. Body composition  
Control HF HF-A HF-E HF-D
DE (kJ/gram) 1.60±0.02a 1.49±0.04ab 1.50±0.05ab 1.58±0.05a 1.41±0.04b
locomotor activity 178±12 174±19 139±14 179±19 119±18*
RQ 0.95±0.01a 0.81±0.01b 0.79±0.01b 0.80±0.01b 0.8±0.01b
* individual comparison vs LF, HF and HF-E found a difference a p=0.1
Table 2. Metabolic phenotyping  
* individual comparison vs LF, HF and HF-E found a difference a p=0.1 
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Variable Control HF HF-A HF-E HF-D
body mass, g (n=18) 27.0 ± 0.4 b 29.6 ± 0.3 a 29.8 ± 0.5 a 29.8 ± 0.5 a 29.2 ± 0.4 a
Body fat mass, % (n=13-17) 9.5 ± 0.4 c 13.4 ± 1.2 a 13.0 ± 1.2 ab 10.3 ± 1.1 bc 13.3 ± 1.1 a
Body lean mass, % (n=13-17) 82.6 ± 0.4 a 79.6 ± 1.2 b 79.5 ± 1.1 b 82.8 ± 1.1 a 79.8 ± 1.0 b
eWAT fat, % BW (n=13-17) 1.3 ± 0.1 b 2.1 ± 0.3 a 2.4 ± 0.4 a 1.3 ± 0.2 b 2.3 ± 0.2 a
eWAT DNA (ng/mg tissu) 
eWAT: epididymal  white Adipose Tissue 
CTRL HF ALA EPA DHA
Leptine (n=8/11) 2.39 ± 0.24 b 2.3 ± 0.53 b 1.82 ± 0.33 b 0.85 ± 0.07 c 5.24 ± 0.55 a
Adiponectine (n=8/11) 9.13 ± 0.55 a 6.14 ± 0.49 b 5.73 ± 0.37 b 5.57 ± 0.31 b 5.68 ± 0.57 b
Figure 1. Adipose Tissue cellularity (n=12/15) Figure 2. Adipose Tissue mRNA level (n=5/6) 
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Figure 3. Kinetic of leptin expression in 3T3-L1 adipocytes with FA treatments (n=5) 
Table 3. Plasma adipokines concentrations 
Leptin and Adiponectin concentration are expressed in ng/ml µg/ml respectively 
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